0QLQ Stock Overview
Develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Ypsomed Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 388.50 |
| 52 Week High | CHF 438.50 |
| 52 Week Low | CHF 279.50 |
| Beta | 1.14 |
| 1 Month Change | 11.56% |
| 3 Month Change | 11.00% |
| 1 Year Change | 1.91% |
| 3 Year Change | 182.23% |
| 5 Year Change | 191.67% |
| Change since IPO | 162.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0QLQ | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 3.4% | 1.8% | -0.2% |
| 1Y | 1.9% | 7.9% | 3.3% |
Return vs Industry: 0QLQ underperformed the UK Medical Equipment industry which returned 7.9% over the past year.
Return vs Market: 0QLQ underperformed the UK Market which returned 3.3% over the past year.
Price Volatility
| 0QLQ volatility | |
|---|---|
| 0QLQ Average Weekly Movement | 5.3% |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 3.4% |
Stable Share Price: 0QLQ has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0QLQ's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 2,644 | Simon Michel | www.ypsomed.com |
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices.
Ypsomed Holding AG Fundamentals Summary
| 0QLQ fundamental statistics | |
|---|---|
| Market cap | CHF 5.33b |
| Earnings (TTM) | CHF 87.50m |
| Revenue (TTM) | CHF 748.87m |
Is 0QLQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0QLQ income statement (TTM) | |
|---|---|
| Revenue | CHF 748.87m |
| Cost of Revenue | CHF 456.80m |
| Gross Profit | CHF 292.07m |
| Other Expenses | CHF 204.56m |
| Earnings | CHF 87.50m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Nov 12, 2025
| Earnings per share (EPS) | 6.41 |
| Gross Margin | 39.00% |
| Net Profit Margin | 11.68% |
| Debt/Equity Ratio | 39.3% |
How did 0QLQ perform over the long term?
See historical performance and comparisonDividends
Does 0QLQ pay a reliable dividends?
See 0QLQ dividend history and benchmarks| Ypsomed Holding dividend dates | |
|---|---|
| Ex Dividend Date | Jul 04 2025 |
| Dividend Pay Date | Jul 08 2025 |
| Days until Ex dividend | 35 days |
| Days until Dividend pay date | 39 days |
Does 0QLQ pay a reliable dividends?
See 0QLQ dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/30 10:55 |
| End of Day Share Price | 2025/05/28 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ypsomed Holding AG is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gaurav Jain | Barclays |
| Hugo Solvet | BNP Paribas Exane |
| Curtis Moiles | BNP Paribas Exane |